:: صفحه اصلي :: درباره نشريه :: جستجو :: ثبت نام :: ارسال مقاله :: تماس با ما ::
:: دوره 6، شماره 2 - ( 9-1398 ) ::
جلد 6 شماره 2 صفحات 14-17 برگشت به فهرست نسخه ها
Prospective on Different Approaches for Vaccine Development Against COVID-19: Past Lessons and Future Challenges
چکیده:   (567 مشاهده)
Since the reemergence of a severe acute respiratory syndrome caused by a novel coronavirus (SARS-CoV-2), the disease caused by this virus, known as COVID-19, has been spreading rapidly all around the world. As of early June 2020, COVID-19 has infected more that 6.6 million people, and has caused more than 390,000 deaths, globally. Similar to its pioneers, namely SARS-CoV and MERS-CoV, there is currently no vaccine or specific antiviral treatment against this virus. This review provides a timely overview on efforts as well as different platforms used for developing an effective vaccine against COVID-19.
متن کامل [PDF 365 kb]   (187 دریافت)    
نوع مطالعه: Review article | موضوع مقاله: Vaccine development, efficacy and safety evaluation
دریافت: 1399/3/19 | پذیرش: 1399/3/19 | انتشار: 1399/3/19
ارسال نظر درباره این مقاله
نام کاربری یا پست الکترونیک شما:

CAPTCHA



XML   English Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Rhimi P, Aghasadeghi M R. Prospective on Different Approaches for Vaccine Development Against COVID-19: Past Lessons and Future Challenges. vacres. 2019; 6 (2) :14-17
URL: http://vacres.pasteur.ac.ir/article-1-194-fa.html

Prospective on Different Approaches for Vaccine Development Against COVID-19: Past Lessons and Future Challenges. Vaccine Research. 1398; 6 (2) :14-17

URL: http://vacres.pasteur.ac.ir/article-1-194-fa.html



دوره 6، شماره 2 - ( 9-1398 ) برگشت به فهرست نسخه ها
Vaccine Research Vaccine Research
Persian site map - English site map - Created in 0.19 seconds with 31 queries by YEKTAWEB 4237
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.